WS #10409
AbbVie close to acquiring Apogee Therapeutics for nearly $11B, sending APGE up 56% premarket.
AbbVie-Apogee M&A
AbbVie close to acquiring Apogee Therapeutics for nearly $11B, sending APGE up 56% premarket.
AbbVie close to acquiring Apogee Therapeutics for nearly $11B, sending APGE up 56% premarket.
AbbVie close to acquiring Apogee Therapeutics for nearly $11B, sending APGE up 56% premarket.